durvalumab,capivasertib,,Capecitabine,Paclitaxel,trastuzumab deruxtecan
astrazeneca,otsuka,daiichi sankyo
['durvalumab', 'breast', 'enhertu', 'capivasertib', '$azn']
destiny-breast06 will be interesting to watch for enhertu combinations. durvalumab (pd-l1), capivasertib (akt inhibitor), plus various chemos and hormone therapies being trialled: $azn $dskny #asco22
Pharma and biotech reporter, found a home at Evaluate Vantage.